GlyTR Therapeutics
PrivateLast Round
Grant
Sep 10, 2025
Total Funding Raised
$8.65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GlyTR Therapeutics is a biotechnology company developing a new class of anti-cancer immunotherapeutic molecules and CAR-T cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlyTR Therapeutics Comparables
Compare GlyTR Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GO Therapeutics | 83% | |
| Tacalyx | 79% | |
| Saccharo | 79% | |
GlyTR Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 10, 2025 | ||||
| Grant | Feb 21, 2025 | ||||
| Grant | Oct 10, 2023 | ||||
| Series A | Oct 22, 2018 | ||||
| Grant | Sep 18, 2018 | ||||
Accelerator | May 17, 2016 |
Key People
Founding team and executive leadership
GlyTR Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| EvoNexus | Accelerator |
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 388% MoM, reaching 1.1K.
- Sep 10, 2025
$464K grant round completed.
GlyTR Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GlyTR Therapeutics's valuation, stock price, and market status.